Comorbidity of mood and anxiety disorders

Depression and Anxiety

Volumn 12, Issue SUPPL. 1, 2000, Pages 69-76

  Kaufman, Joan ^a   Charney, Dennis ^b  

^a YALE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anxiety disorders; Comorbidity; Depression

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AFFECTIVE NEUROSIS; ALCOHOL ABUSE; ANXIETY NEUROSIS; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; HUMAN; PANIC; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; REVIEW; SOCIAL PHOBIA; SUBSTANCE ABUSE; SUICIDE;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMORBIDITY; HUMANS; MONOAMINE OXIDASE INHIBITORS; MOOD DISORDERS; PANIC DISORDER; PHOBIC DISORDERS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0033762426     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K     Document Type: Review

References (75)

1. Suicide risk in patients with major depressive disorder
2. The role of corticotropin-releasing factor in depression and anxiety disorders
3. Predicting prospective episodes of depression in patients with panic disorder: A longitudinal study
4. Current treatments of the anxiety disorders in adults
5. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety
6. Clinical guidelines for establishing remission in patients with depression and anxiety. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients
7. Family history of anxiety disorders in control subjects with lactate-induced panic attacks
8. 2-induced panic attacks: A twin study
9. Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness
10. Traumatic events and posttraumatic stress disorder in an urban population of young adults
11. Psychiatric sequelae of posttraumatic stress disorder in women
12. Trauma and posttraumatic stress disorder in the community: The 1996 Detroit Area Survey of Trauma
13. Life events and affective disorder: Replications and limitations
14. Personality and psychopathology: Genetic perspectives
15. Comorbidity in child psychopathology: Concepts, issues and research strategies
16. 2 challenge
17. A functional neuroanatomy of anxiety and fear: Implications for the pathophysiology and treatment of anxiety disorders
18. Hypersensitivity to carbon dioxide as a disease-specific trait marker
19. Pharmacotherapy of posttraumatic stress disorder: Treatment options, long-term follow-up, and predictors of outcome
20. The epidemiology of social phobia: Findings from the Duke Epidemiological Catchment Area Study
21. A family study of chronic post-traumatic stress disorder following rape trauma
22. Epidemiology of psychiatric disorders in Edmonton. Panic disorder
23. Epidemiology of psychiatric disorders in Edmonton. Phobic disorders
24. The reliability of abuse history reports: A comparison of two inquiry formats
25. Epidemiology of social phobia: A clinical approach
26. Anxiety disorders in major depression
27. Psychosocial treatment of posttraumatic stress disorder
28. Development and vulnerability: New perspectives for anxiety disorders
29. A direct interview family study of social phobia
30. The occurrence of a prodrome of generalized anxiety in panic disorder
31. Comorbidity of anxiety disorders in a multicenter anxiety study
32. Specificity of substance use in anxiety-disordered subjects
33. The infrequency of 'pure culture' diagnoses among the anxiety disorders
34. Comorbidity of depression and panic disorder
35. SSRIs and SMRIs: Broad spectrum of efficacy, beyond major depression
36. Predictors of panic attacks in adolescents
37. Post-traumatic stress disorder in the general population. Findings of the epidemiologic catchment area survey
38. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
39. Panic disorder with smothering symptoms: Evidence for increased risk in first-degree relatives
40. Comorbidity as a fundamental feature of generalized anxiety disorders: Results from the National Comorbidity Study (NCS)
41. Early childhood predictors of adult anxiety disorders
42. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression
43. Remission and relapse in subjects with panic disorder and panic with agoraphobia: A prospective short-interval naturalistic follow-up
44. The genetic epidemiology of phobias in women. The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia
45. Major depression and generalized anxiety disorder. Same genes, (partly) different environments?
46. Panic disorder in women: A population-based twin study
47. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey
48. Posttraumatic stress disorder in the National Comorbidity Survey
49. Lifetime panic-depression comorbidity in the National Comorbidity Survey
50. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: A dose-response study. Venlafaxine Investigator Study Group
51. Anxious children in adulthood: A prospective study of adjustment
52. Panic disorder and major depression. Increased risk of depression, alcoholism, panic, and phobic disorders in families of depressed probands with panic disorder
53. Major depression and panic disorder: A family study perspective
54. Emotion circuits in the brain [In Process Citation]
55. Childhood separation anxiety, disorder in patients with adult anxiety disorders
56. Neural circuits mediating stress
57. Subpopulations of early separation anxiety: Relevance to risk of adult anxiety disorders
58. Comorbidity and social phobia: Evidence from clinical, epidemiologic, and genetic studies
59. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions
60. A family study of generalized anxiety disorder
61. A pro-spective, follow-along study of the course of social phobia: II. Testing for basic predictors of course
62. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking
63. A meta-analysis of the effects of venlafaxine on anxiety associated with depression
64. Psychotherapy in the overall management strategy for social anxiety disorder
65. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder
66. Is early separation anxiety a risk factor for adult panic disorder? A critical review
67. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group
68. A twin study of DSM-III-R anxiety disorders
69. Panic and phobic anxiety: Defining phenotypes for genetic studies
70. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms
71. The cross-national epidemiology of panic disorder
72. The cross-national epidemiology of social phobia: A preliminary report
73. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey
74. Phenomenology and course of generalized anxiety disorder
75. Chronicity in posttraumatic stress disorder (PTSD) and predictors of course of comorbid PTSD in patients with anxiety disorders